A propensity-score matched cohort study found a significantly reduced risk of recurrence of bladder cancer in patients who ...

Blue light cystoscopy had a statistically significant reduction in risk of recurrence versus white light cystoscopy in ...

Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the study "Oncologic Outcomes of Blue Light Cystoscopy in ...

OSLO, Norway, March 14, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the study "Oncologic Outcomes of Blue Light Cystoscopy in an Equal ...

Bladder cancer is one of the most commonly diagnosed cancers, yet many patients face delays in diagnosis or struggle to find the right care. Are you navigating a bladder cancer diagnosis or unsure of ...

With Prime Minister Mark Carney's call for a federal election on March 23 and Canadians going to the polls on April 28, Canada's pharmacy sector is poised to work alongside government leaders to ...

CSI, a leading provider of end-to-end financial software and technology, announced today that president and CEO David Culbertson will transition to a new role as vice chair of the board of directors.